ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,414Medicare Part D Prescriptions Filled, Including Refills

Rank: 251 out of 5176

$749K Total Retail Price of All Prescriptions

Rank: 539 out of 5176

449 Patients Receiving at Least One Drug in Part D
71%Patients 65 Years and Older
92% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 449 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

11% of this provider’s 449 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

2% of this provider’s 10,507 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

30% of this provider’s prescriptions were for brand-name drugs, compared to an average of 30%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
PRAVASTATIN SODIUM 677 449 1 23
OMEPRAZOLE 537 400 2 3
METFORMIN HCL 511 385 3 7
ZOLPIDEM TARTRATE 409 219 4 17
SIMVASTATIN 392 318 5 1
ALENDRONATE SODIUM 381 320 6 18
LISINOPRIL 332 257 7 5
AMLODIPINE BESYLATE 318 260 8 2
METOPROLOL TARTRATE 273 236 9 6
LOSARTAN POTASSIUM 271 220 10 14
MELOXICAM 224 167 11 53
CRESTOR 220 163 12 15
ATENOLOL 209 168 13 12
HYDROCHLOROTHIAZIDE 208 149 14 10
LEVOTHYROXINE SODIUM 204 156 15 4
METOPROLOL SUCCINATE 199 160 16 11
NABUMETONE 198 116 17 217
DONEPEZIL HCL 197 183 18 28
LOVAZA 192 133 19 43
EVISTA 184 139 20 65
LOSARTAN-HYDROCHLOROTHIAZIDE 175 121 21 35
ZETIA 174 117 22 68
MECLIZINE HCL 162 132 23 81
GLIPIZIDE 160 127 24 63
DIOVAN 155 131 25 19
GLIPIZIDE XL 153 119 26 83
IBUPROFEN 150 83 27 72
DICLOFENAC SODIUM 146 104 28 160
FUROSEMIDE 143 110 29 8
LANTUS 142 108 30 66
SERTRALINE HCL 139 87 31 30
ATORVASTATIN CALCIUM 137 100 32 9
ACTOS 127 93 33 85
NEXIUM 124 53 34 16
CARVEDILOL 116 110 35 24
SINGLE USE SWAB 115 92 36 108
DIOVAN HCT 111 78 37 39
GABAPENTIN 110 94 38 21
ALCOHOL PREP PADS 110 79 38 198
CLOPIDOGREL 110 100 38 26
HYDROXYZINE HCL 109 52 R 41 213
VENTOLIN HFA 96 43 42 64
ADVAIR DISKUS 95 39 43 32
CLOTRIMAZOLE-BETAMETHASONE 94 81 44 94
VERAPAMIL ER 94 49 44 155
TRAMADOL HCL-ACETAMINOPHEN 93 56 46 116
NIFEDIPINE ER 93 85 46 48
RAMIPRIL 89 61 48 50
LANTUS SOLOSTAR 89 60 48 70
ACETAMINOPHEN-CODEINE 88 44 S3 50 127
INDAPAMIDE 85 42 51 257
AZITHROMYCIN 84 55 52 42
PLAVIX 79 73 53 29
DESOXIMETASONE 78 70 54 278
JANUVIA 76 58 55 25
ENALAPRIL MALEATE 75 59 56 22
FLUTICASONE PROPIONATE 74 36 57 38
RANITIDINE HCL 72 53 58 36
AMITRIPTYLINE HCL 68 61 R 59 177
ATENOLOL-CHLORTHALIDONE 65 54 60 161
FINASTERIDE 62 54 61 69
PIOGLITAZONE HCL 61 40 R 62 237
TAMSULOSIN HCL 60 46 63 20
SINGULAIR 60 13 63 62
QUETIAPINE FUMARATE 59 58 65 75
JANUMET 56 51 66 77
WARFARIN SODIUM 55 49 67 13
AMLODIPINE BESYLATE-BENAZEPRIL 54 48 68 55
BUSPIRONE HCL 53 28 69 183
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 16, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.